BDX

Becton, Dickinson and Company | Cotação de Ações

Última atualização22/04/2025, 17:00:02

PreçoUS$ 199,88

Variação (dia)US$ 3,27 (1.66%)▲

Min. 52 SemanasUS$ 193,03

Máx. 52 SemanasUS$ 251,99

Capitalização de mercado--

Endereço: 1 Becton Drive, Franklin Lakes, NJ, 07417-1880

Telefone: 201 847 6800

Funcionários: 70.000

Becton, Dickinson and CompanyBDX

US$ 199,88

+ 3,271,7%

22/04/2025 17:00:02

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atualUS$ 199,88

Valor de mercado--

AberturaUS$ 204,85

Preço máximoUS$ 200,35

Preço mínimoUS$ 197,45

VolumeUS$ 1,6 mi

Fechamento anteriorUS$ 196,61

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation systems, and medication inventory optimization and tracking systems; hemodynamic monitoring systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Ações relacionadas

Baxter International Inc.

BAX ▲0.34% | US$ 31,33

Air Products and Chemicals, Inc.

APD ▲2.12% | US$ 319,92

Cardinal Health, Inc.

CAH ▲0.87% | US$ 127,14

Dover Corporation

DOV ▲2.65% | US$ 197,73

Illinois Tool Works Inc.

ITW ▲4.65% | US$ 261,03

Busque ativos específicos e obtenha informações detalhadas sobre suas cotações

Utilize a função de busca para encontrar informações detalhadas sobre ativos específicos. Oferecemos dados precisos e atualizados, permitindo que você tome decisões informadas com base nas informações mais recentes do mercado.

Fique por dentro das últimas notícias do mundo financeiro em nosso Blog

Mantenha-se atualizado com as últimas notícias financeiras em nosso Blog. Publicamos artigos informativos e análises de especialistas para fornecer insights valiosos sobre o cenário financeiro em constante evolução.

Assine nossa newsletter para receber atualizações gratuitas por e-mail

Mantenha-se informado assinando nossa newsletter. Receba atualizações gratuitas por e-mail, incluindo rendimentos, novidades do mercado e insights valiosos. Estamos comprometidos em fornecer informações relevantes diretamente à sua caixa de entrada.